Indian Court Reluctantly Backs Biosimilars of Roche’s Herceptin

Drug Industry Daily
A A
Despite grave doubts, an Indian high court judge is allowing two drugmakers to market and produce contested biosimilars of Roche’s breast cancer therapy Herceptin.

To View This Article:

Login

Subscribe To Drug Industry Daily